CNS oncology
ISSN:2045-0915

CNS oncology

学科领域:-
是否预警:不在预警名单内
是否OA:
录用周期:13 Weeks
新锐分区:-
年发文量:-
影响因子:0
JCR分区:Q0(未被收录)

基本信息

-
2045-0915Scopus收录/DOAJ开放期刊
0
0
-
WOS期刊SCI分区  2024-2025最新升级版
暂无按学科分区信息
暂无h-index数据
-
--13 WeeksUSD1415Medicine-Neurology (clinical)
0%
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
0.00%--
CiteScore:4.90
SJR:1.123
SNIP:1.124
学科类别分区排名百分位
大类:Medicine
小类:Neurology (clinical)
Q2
143 / 400
大类:Medicine
小类:Neurology
Q2
76 / 194

期刊高被引文献

Analysis of cell-free circulating tumor DNA in 419 patients with glioblastoma and other primary brain tumors
来源期刊:CNS OncologyDOI:10.2217/cns-2018-0015
Use of the Response Assessment in Neuro-Oncology (RANO) criteria in clinical trials and clinical practice
来源期刊:CNS OncologyDOI:10.2217/cns-2018-0007
Pleomorphic xanthoastrocytoma: a brief review
来源期刊:CNS OncologyDOI:10.2217/cns-2019-0009
Efficacy and safety of immune checkpoint blockade for brain metastases
来源期刊:CNS OncologyDOI:10.2217/cns-2018-0018
Shifting paradigms: whole brain radiation therapy versus stereotactic radiosurgery for brain metastases
来源期刊:CNS OncologyDOI:10.2217/cns-2018-0016
An early feasibility study of the Nativis Voyager® device in patients with recurrent glioblastoma: first cohort in US
来源期刊:CNS OncologyDOI:10.2217/cns-2018-0013
Comparative proteogenomic characterization of glioblastoma
来源期刊:CNS OncologyDOI:10.2217/cns-2019-0003
The role of chemotherapy in the treatment of central neurocytoma
来源期刊:CNS OncologyDOI:10.2217/cns-2019-0012
Challenges of targeting BRAF V600E mutations in adult primary brain tumor patients: a report of two cases
来源期刊:CNS OncologyDOI:10.2217/cns-2019-0018
A feasibility study of the Nativis Voyager® device in patients with recurrent glioblastoma in Australia
来源期刊:CNS OncologyDOI:10.2217/cns-2018-0017
Biological intratumoral therapy for the high-grade glioma part I: intratumoral delivery and immunotoxins
来源期刊:CNS OncologyDOI:10.2217/cns-2019-0001
Radiographic appearance of leptomeningeal disease in patients with EGFR-mutated non-small-cell lung carcinoma treated with tyrosine kinase inhibitors: a case series
来源期刊:CNS OncologyDOI:10.2217/cns-2019-0010
Prediagnostic presentations of glioma in primary care: a case–control study
来源期刊:CNS OncologyDOI:10.2217/cns-2019-0015
Utility of flouro-deoxy-glucose positron emission tomography/computed tomography in the diagnostic and staging evaluation of patients with primary CNS lymphoma
来源期刊:CNS OncologyDOI:10.2217/cns-2019-0016
How far will the Voyager® take us?
来源期刊:CNS OncologyDOI:10.2217/cns-2018-0019
Biological intratumoral therapy for the high-grade glioma part II: vector- and cell-based therapies and radioimmunotherapy
来源期刊:CNS OncologyDOI:10.2217/cns-2019-0002
A case report of high-grade astroblastoma in a young adult
来源期刊:CNS OncologyDOI:10.2217/cns-2018-0012
Journal Watch: our panel of experts highlight the most important research articles across the spectrum of topics relevant to the field of CNS oncology
来源期刊:CNS OncologyDOI:10.2217/cns-2019-0005
Biweekly fotemustine schedule for recurrent glioblastoma in the elderly: activity and toxicity assessment of a multicenter study
来源期刊:CNS OncologyDOI:10.2217/cns-2019-0004
An audit of the management of elderly patients with glioblastoma in the UK: have recent trial results changed treatment?
来源期刊:CNS OncologyDOI:10.2217/cns-2019-0017
Hemophagocytic lymphohistiocytosis in a patient with glioblastoma: a case report
来源期刊:CNS OncologyDOI:10.2217/cns-2019-0013
Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series
来源期刊:CNS OncologyDOI:10.2217/cns-2019-0007

相关文章